Laxodal

Sodium picosulfate, the active ingredient in Laxodal, is a stimulant laxative presented as an oral dosage form for oral use. It is employed to relieve occasional constipation in adults. GNH USA supplies Laxodal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxodal is a stimulant laxative used to manage conditions affecting bowel motility. - Occasional constipation: promotes regular bowel movements and relieves infrequent constipation. - Bowel preparation for diagnostic procedures: facilitates colon cleansing when used under medical supervision. - Opioid‑induced constipation: may be considered as part of a regimen to counteract reduced gastrointestinal motility.

Sodium picosulfate can cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps: mild to moderate discomfort in the abdomen. - Diarrhea: loose stools occurring after dosing. - Nausea: feeling of queasiness. - Flatulence: increased gas production. - Thirst: sensation of increased need for fluids. - Electrolyte imbalance: mild changes in serum electrolytes.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Electrolyte disturbances: significant hyponatremia or hypokalemia. - Rectal bleeding: unexpected bleeding from the rectum. - Allergic reaction: rash, itching, or swelling. - Persistent abdominal pain: pain lasting beyond expected duration. - Severe colitis: inflammation of the colon requiring urgent care.

Before using Laxodal, consider the following safety measures. - Assess renal function: avoid use in severe renal impairment. - Evaluate electrolyte status: correct existing imbalances prior to therapy. - Monitor fluid intake: ensure adequate hydration to prevent dehydration. - Use with caution in elderly: increased sensitivity to laxative effects. - Contraindications: do not use in cases of intestinal obstruction or acute abdominal conditions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Sodium picosulfate may interact with other agents that affect gastrointestinal motility or fluid balance.

Major Interactions (Avoid): - Anticholinergic drugs: may reduce laxative efficacy. - Loop diuretics: increase risk of electrolyte depletion. - Potassium‑sparing diuretics: potential for hyperkalemia when combined with fluid loss.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of gastrointestinal irritation. - Opioid analgesics: may counteract laxative effect, requiring dose adjustment. - Mineral supplements (e.g., calcium, iron): may alter absorption or cause constipation.